Trials / Completed
CompletedNCT03242525
Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis
Examination of the Time Advantage of Point of Care Testing (POCT) Compared to the Conventional Central Laboratory Analysis in Intraclinical Patient Care
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to quantify the time advantage achieved by the use of POCT compared to conventional coagulation diagnostics. A further objective of this study is an analysis of the result quality of POCT for the prothrombin time / international normalized ratio.
Detailed description
In order to be able to carry out a targeted coagulation therapy for the time-critical treatment of coagulopathic emergency patients, knowledge of the hemostatic potential is necessary. After taking blood samples for coagulation diagnostics, they are sent to the central laboratory. After the analysis and validation the electronic provision of the results takes place. The loss of time by sample transport, analysis and breadth of the results extends the duration until therapy can be started. The period of time until these analysis results are determined depends on several factors like daytime, day of week and location of the sample consignor and the availability of the laboratory. Not every clinic is connected to an internal tube mail system so that the samples have to be sent partly with a transport service. In recent years, Point of Care (POCT) devices have become an increasingly important tool for diagnosing coagulopathic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | POCT and central laboratory blood analysis | In every participant blood analysis will be performed by POCT and central laboratory investigating the time advantage. |
Timeline
- Start date
- 2017-10-26
- Primary completion
- 2018-11-30
- Completion
- 2019-02-28
- First posted
- 2017-08-08
- Last updated
- 2019-03-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03242525. Inclusion in this directory is not an endorsement.